LOG IN
SIGN UP
MARKET
NKTX
NKTX
Nkarta, Inc.
NASDAQ
4.750
+0.160
+3.49%
After Hours: 4.990 +0.24 +5.05% 19:58 06/02 EDT
OPEN
4.680
PREV CLOSE
4.590
HIGH
4.840
LOW
4.600
VOLUME
170.01K
TURNOVER
0
52 WEEK HIGH
18.48
52 WEEK LOW
3.120
MARKET CAP
232.44M
P/E (TTM)
-1.9051
1D
5D
1M
3M
1Y
5Y
Nkarta (NKTX) Receives a Buy from SVB Securities
TipRanks · 05/17 00:36
Stifel Maintains Nkarta (NKTX) Buy Recommendation
NASDAQ · 05/12 20:17
Needham Reiterates Nkarta (NKTX) Buy Recommendation
NASDAQ · 05/12 20:17
Analysts Are Bullish on Top Healthcare Stocks: Nkarta (NKTX), Indaptus Therapeutics (INDP)
TipRanks · 05/12 16:40
Analysts Are Bullish on These Healthcare Stocks: Astria Therapeutics (ATXS), Nkarta (NKTX)
TipRanks · 05/12 10:30
--Stifel Trims Price Target on Nkarta to $18 From $21, Maintains Buy Rating
--Stifel Trims Price Target on Nkarta to $18 From $21, Maintains Buy Rating
MT Newswires · 05/12 09:53
Nkarta GAAP EPS of -$0.63 beats by $0.07
Seeking Alpha · 05/11 21:35
BRIEF-Nkarta Reports First Quarter 2023 Financial Results
Reuters · 05/11 21:03
About NKTX
Nkarta, Inc. is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies to treat cancer. The Company’s product candidates include NKX101 and NKX019, which are in ongoing Phase I clinical trials. NKX101 is an allogeneic, cryopreserved, off-the-shelf cancer immunotherapy candidate that uses natural killer (NK) cells derived from the peripheral blood of healthy donors. It is engineered with a chimeric antigen receptor (CAR) targeting NKG2D ligands on tumor cells. NKX019 is an allogeneic, cryopreserved, off-the-shelf cancer immunotherapy candidate that uses natural killer (NK) cells derived from the peripheral blood of healthy adult donors. It is engineered with a humanized CD19-directed CAR for enhanced tumor cell targeting and a proprietary, membrane-bound form of interleukin-15 (IL-15) for greater persistence and activity without exogenous cytokine support.
Webull offers kinds of Nkarta Inc stock information, including NASDAQ:NKTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NKTX stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading NKTX stock methods without spending real money on the virtual paper trading platform.